Verrica Pharmaceuticals Announces Dosing of the First Patient in Part 2 of Phase 2 Study Evaluating VP-315 for the Treatment of Basal Cell CarcinomaGlobeNewsWire • 04/12/23
Verrica Pharmaceuticals Announces Presentation at the 22nd Annual Needham Virtual Healthcare ConferenceGlobeNewsWire • 04/11/23
Verrica Pharmaceuticals Reports Fourth Quarter and Full-Year 2022 Financial ResultsGlobeNewsWire • 03/06/23
Verrica Pharmaceuticals Announces Participation at The Cowen 43rd Annual Health Care ConferenceGlobeNewsWire • 02/28/23
Verrica Pharmaceuticals Announces FDA Acceptance of Filing of Resubmitted NDA for VP-102 for the Treatment of Molluscum ContagiosumGlobeNewsWire • 02/27/23
Verrica Announces Pricing of $32.5 Million Underwritten Offering of Common Stock and Pre-Funded WarrantsGlobeNewsWire • 02/21/23
Verrica Pharmaceuticals Announces Resubmission of New Drug Application for VP-102 for the Treatment of Molluscum ContagiosumGlobeNewsWire • 01/24/23
Verrica Pharmaceuticals Announces the Successful Technology Transfer of Bulk Solution Manufacturing of VP-102 to Piramal Pharma SolutionsGlobeNewsWire • 01/04/23
Verrica Pharmaceuticals Announces Participation in the H.C. Wainwright 24th Annual Global Investment ConferenceGlobeNewsWire • 08/31/22
VRCA SHAREHOLDER ALERT: Jakubowitz Law Reminds Verrica Shareholders of a Lead Plaintiff Deadline of August 5, 2022PRNewsWire • 08/05/22
VRCA DEADLINE TODAY: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Verrica Pharmaceuticals Inc. Investors to Secure Counsel Before Important August 5 Deadline in Securities Class Action - VRCANewsfile Corp • 08/05/22
DEADLINE TODAY: The Schall Law Firm Encourages Investors in Verrica Pharmaceuticals Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 08/05/22
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Verrica Pharmaceuticals Inc. (VRCA)Business Wire • 08/04/22
INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Verrica Pharmaceuticals Inc. with Losses of $100,000 to Contact the FirmBusiness Wire • 08/04/22
DEADLINE TOMORROW: The Schall Law Firm Encourages Investors in Verrica Pharmaceuticals Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 08/04/22
VRCA LAWSUIT ALERT: Levi & Korsinsky Notifies Verrica Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlinePRNewsWire • 08/04/22
Verrica Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before August 5, 2022 to Discuss Your Rights - VRCANewsfile Corp • 08/04/22
FRIDAY DEADLINE NOTICE: The Schall Law Firm Encourages Investors in Verrica Pharmaceuticals Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 08/03/22
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Verrica Pharmaceuticals Inc. with Losses of $100,000 to Contact the FirmBusiness Wire • 08/03/22
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Verrica Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 5, 2022 - (NASDAQ: VRCA)PRNewsWire • 08/03/22
VRCA Investors Have Opportunity to Lead Verrica Pharmaceuticals Inc. Securities Fraud LawsuitPRNewsWire • 08/02/22